ArticleFrontiers in endocrinology2026
A positive linear association between uric acid and the risk of gestational diabetes mellitus: a single-center retrospective study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to examine the association between maternal uric acid (UA) concentrations measured prior to 24 weeks of pregnancy and the risk of gestational diabetes mellitus (GDM) between 24 and 28 weeks. Methods: In this retrospective cohort conducted at a single institution, 847 expectant mothers receiving prenatal services at Zhengzhou People's Hospital from August to December 2024 were enrolled. All participants had their UA levels measured prior to 24 gestational weeks, followed by a 75 g oral glucose tolerance assessment conducted between weeks 24 and 28. Multivariable logistic regression analysis was performed to evaluate the association between UA levels and the risk of GDM, supplemented by subgroup analysis, sensitivity analysis, and analytical procedures including receiver operating characteristic (ROC) curve evaluation and modeling with restricted cubic spline (RCS). Results: Among 847 enrolled pregnancies, the proportion with GDM was 21.1% (n = 179). Multivariate logistic regression showed that each 1 µmol/L or each one-standard-deviation elevation in serum UA corresponded to a markedly greater risk of GDM (OR: 1.005, 95% CI: 1.001-1.009; OR: 1.274, 95% CI: 1.062-1.528, respectively). In comparison to the lowest UA tertile (T1), T2 and T3 exhibited elevated risk for GDM, with ORs of 1.976 (95% CI: 1.203-3.247) and 2.468 (95% CI: 1.520-4.007), respectively. Subgroup analyses revealed that in women aged > 30, with gravidity < 2, parity < 2, or body mass index before conception below 24 kg/m Conclusion: Higher maternal serum UA measurements taken prior to 24 gestational weeks were strongly linked to GDM risk during weeks 24-28.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.